China Universal Asset Management Company’s Capricor Therapeutics CAPR Stock Holding History

China Universal Asset Management Company’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.5K	Buy	+1,600	New	+$48.5K	﹤0.01%	474

Other funds holding CAPR

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

China Universal Asset Management Company's CAPR Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Capricor Therapeutics (CAPR) in Q2 2026: 1,600 shares worth $38.5K. The stake represents ﹤0.01% of the portfolio and ranks #474 among its holdings.

14 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

China Universal Asset Management Company held 1,600 shares of Capricor Therapeutics worth $38.5K as of Q2 2026.
Capricor Therapeutics was a new China Universal Asset Management Company position in Q2 2026.
Capricor Therapeutics made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #474 holding.
14 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.